HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Álvarez-Lafuente, R Articles by Lamas, J R Search for Related Content PubMed PubMed Citation Articles by Álvarez-Lafuente, R Articles by Lamas, J R

Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction

¹ Rheumatology Service, Hospital Clínico San Carlos, C/ Prof Martín Lagos s/n 28040 Madrid, Spain
² Pathology Service, Hospital Clínico San Carlosm, C/ Prof Martín Lagos s/n 28040 Madrid, Spain

Correspondence to:
Correspondence to:
Dr B Fernández-Gutiérrez
bfernandez.hcsc{at}salud.madrid.org

ABSTRACT
Objective: To evaluate the role of parvovirus B19 (B19), varicella zoster virus (VZV), and human herpes virus 6 (HHV-6) in the aetiopathology of giant cell arteritis (GCA).

Methods: Temporal artery biopsy specimens from 57 patients with GCA and 56 controls were investigated. DNA was obtained by biopsy, and quantitative real time polymerase chain reaction assay performed to establish the prevalence and viral load of B19, VZV, and HHV-6. Amplification of the human ß-globin gene was used as internal positive control.

Results: (a) B19 was detected in 31/57 (54%) patients (median viral load 45.2 (25th–75th centiles 0–180.2) copies/µg DNA) v 21/56 (38%) controls (median viral load 0 (0–66.7) copies/µg of DNA; p = 0.07 for DNA prevalence, p = 0.007 for viral load. Among 31 B19 positive samples, 21 (68%) patients with biopsy proven GCA had >10² B19 copies/µg of DNA v 5/21 (24%) controls; p = 0.001. (b) No significant difference was found for VZV (p = 0.94 for DNA prevalence; p = 0.76 for viral load) and HHV-6 (p = 0.89 for DNA prevalence; p = 0.64 for viral load) in the GCA group compared with controls.

Conclusion: B19 may have a role in the aetiopathology of GCA, particularly in those patients with high viral load; no evidence was found for VZV and HHV-6.

Abbreviations: B19, parvovirus B19; GCA, giant cell arteritis; HHV-6, human herpes virus 6; q-rtPCR, quantitative real time polymerase chain reaction; TAB, temporal artery biopsy; VZV, varicella zoster virus

Keywords: parvovirus B19; varicella zoster virus; herpes virus 6; giant cell arteritis

This article has been cited by other articles:

				Z Sachetto, S C B Costa, P D Andrade, R A Conde, E M I Amstalden, A M Samara, and S R M Fernandes No evidence of parvovirus B19 in tissue samples from patients with polyarteritis nodosa and microscopic polyangiitis as assessed by the polymerase chain reaction Ann Rheum Dis, March 1, 2006; 65(3): 418 - 420. [Full Text] [PDF]